941 results on '"Juliusson, Gunnar"'
Search Results
152. No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy
153. Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986–2009: a population-based study
154. Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
155. Hypocholesterolaemia In Hairy Cell Leukaemia [with Reply]
156. Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients
157. Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
158. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
159. Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma
160. Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry
161. A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
162. Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors
163. A Distributed International Patient Data Registry for Hairy Cell Leukemia
164. Mutational and Clonal Dynamics in Patient-Derived Xenografts of Acute Myeloid Leukemia
165. DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma
166. Monitoring Minimal Residual Disease in AML By Patient Specific Mutational Fingerprint Using Multiplex PCR and Deep Sequencing
167. The prognostic impact of FLT3-ITD and NPM1mutation in adult AML is age-dependent in the population-based setting
168. Prognostic Value of Measurable Residual Disease in High-Risk Myelodysplastic Syndromes with Intensive Chemotherapy Treatment: Analysis of HOVON-SAKK Studies
169. Vaccine-Preventable Infections in Multiple Myeloma: A Population-Based Study on 8672 Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry
170. Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry
171. The Impact of Fitness and Dose Intensity on Safety and Efficacy Outcomes after Venetoclax-Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia
172. The Laip-Based-Dfn Approach Is Superior in Terms of Useful MRD Results As Compared to the Laip Approach after Cycle II in Acute Myeloid Leukemia
173. Selective killing of candidate AML stem cells by antibody targeting of IL1RAP
174. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients
175. Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients
176. Improved minimal residual disease detection by targeted quantitative polymerase chain reaction inNucleophosmin 1type a mutated acute myeloid leukemia
177. Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
178. Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis
179. EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player
180. ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome
181. Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014
182. Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry
183. CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference
184. Comprehensive Prospective Next Generation Sequencing of Acute Myeloid Leukemia
185. Small molecule screen identifies differentiation-promoting compounds targeting genetically diverse acute myeloid leukaemia
186. No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
187. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
188. Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986–2009: a population-based study.
189. Differentiation targeted compound screen of acute myeloid leukemia
190. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
191. Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia
192. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
193. Cancer Risk is Not Increased in People with Relapsing Multiple Sclerosis Taking Cladribine (P7.011)
194. Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
195. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
196. Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups
197. A pragmatic approach to dealing with fingolimod-related lymphopaenia in Europe
198. Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia
199. Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia
200. Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.